Used ITC Hemochron Jr. Signature+ ITC Hemochron Jr. Signature+ Whole

Hemochron 100. Gem Hemochron 100 Whole Blood Hemostasis System YouTube The GEM Hemochron 100 system is currently in clinical use in several European countries and will be commercialized in the US in early 2022 The GEM Hemochron 100 offers the highest level of speed, simplicity, and connectivity in whole blood hemostasis testing, the Werfen press release stated

180 Hartwell Road Bedford, MA 01730-2443 USA 1-800-955-9525 [email protected] . Producing ACT results faster than traditional systems, the GEM Hemochron 100 system optimizes heparin dosing and enables rapid initiation of critical procedures for enhanced patient management

FDA Clears GEM Hemochron 100 Blood Hemostasis Testing System RT

The GEM Hemochron 100 also offers an encrypted connection to ensure the security of patient data The GEM Hemochron 100 system is currently in clinical use in several European countries and will be commercialized in the US in early 2022 The GEM Hemochron 100 is designed for invasive procedures requiring heparin dose adjustment, where rapid and accurate ACT results are essential

GEM® Hemochron™ 100 Werfen em Brasil. Two ACT tests, ACT+ for moderate-high heparin doses (1-6 IU/mL) and ACT-LR for low-moderate (up to 2.5 IU/mL) heparin doses, offer testing flexibility in a variety of clinical settings, including the. Leveraging leading Hemochron technology, the GEM Hemochron 100 system, delivers fast, actionable activated clotting time (ACT) results in minutes, informing patient-management decisions and helping improve workflow at the point of care (POC).

Werfen North America on LinkedIn We are excited to announce the GEM. GEM Hemochron 100 Whole Blood Hemostasis system delivers quality results for monitoring and guiding unfractionated heparin therapy during cardiovascular procedures, including cardiac ablation and extracorporeal life support 180 Hartwell Road Bedford, MA 01730-2443 USA 1-800-955-9525 [email protected] .